The BEXXAR (R) therapeutic regimen (Tositumomab and Iodine I 131 tositumomab) produced durable complete remissions in heavily pretreated patients with non-Hodgkin's lymphoma (NHL), rituximab-relapsed/refractory disease, and rituximab-naive disease Meeting Abstract
| Authors: | Coleman, M.; Kaminski, M. S.; Knox, S. J.; Zelenetz, A. D.; Vose, J. M. |
| Abstract Title: | The BEXXAR (R) therapeutic regimen (Tositumomab and Iodine I 131 tositumomab) produced durable complete remissions in heavily pretreated patients with non-Hodgkin's lymphoma (NHL), rituximab-relapsed/refractory disease, and rituximab-naive disease |
| Meeting Title: | 45th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 102 |
| Issue: | 11 Pt. 1 |
| Meeting Dates: | 2003 Dec 6-9 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2003-11-01 |
| Start Page: | 29A |
| Language: | English |
| ACCESSION: | WOS:000186536700090 |
| PROVIDER: | wos |
| PUBMED: | 14650391 |
| Notes: | Meeting Abstract: 89 -- 45th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2003 -- SAN DIEGO, CALIFORNIA -- Source: Wos |
